ADB to give $200 mn to companies manufacturing products to combat coronavirus

The Asian Development Bank (ADB) on Thursday said it will provide $200 million (about Rs 1,480 crore) to companies manufacturing and distributing medicines, and other items needed to combat the novel coronavirus (COVID-19)

Press Trust of India March 12, 2020 16:08:06 IST
ADB to give $200 mn to companies manufacturing products to combat coronavirus
  • The funds will be made available through ADB's Supply Chain Finance Program and provided to selected companies within weeks, the Manila-headquartered multilateral funding agency said in a release

  • Companies manufacturing and distributing products, including medicines and personal protective equipment, are increasingly strained as production and distribution ramp up to address COVID-19, it said

  • The support from ADB, working in partnership with commercial banks, will provide such companies in Asia and the Pacific with additional working capital to meet expansion and other requirements

New Delhi: The Asian Development Bank (ADB) on Thursday said it will provide $200 million (about Rs 1,480 crore) to companies manufacturing and distributing medicines, and other items needed to combat the novel coronavirus (COVID-19).

The funds will be made available through ADB's Supply Chain Finance Program and provided to selected companies within weeks, the Manila-headquartered multilateral funding agency said in a release.

Companies manufacturing and distributing products, including medicines and personal protective equipment, are increasingly strained as production and distribution ramp up to address COVID-19 , it said.

ADB to give 200 mn to companies manufacturing products to combat <span class=coronavirus " width="380" height="285" />

Representational image. News 18.

The support from ADB, working in partnership with commercial banks, will provide such companies in Asia and the Pacific with additional working capital to meet expansion and other requirements.

"The support will target companies in the supply chain that are critical to fighting the virus," ADB Head of Trade and Supply Chain Finance Steven Beck said.

"We're looking to support companies that want to ramp up production and therefore need to engage suppliers," he said.

Given that a single pool of supply chain finance is typically used for a subsequent delivery over a period of 120–180 days, the $200 million facility could support more than $400 million of financing over the next 12 months, the release said.

Fifty-fifty risk sharing from partner commercial banks could boost support under the facility to $800 million over the same period.

"ADB is closely monitoring the impact of COVID-19 on trade finance and is in regular contact with client banks to assess whether additional support is required," it said.

Earlier on 7 February, ADB came up with a $2 million assistance for COVID-19 to enhance detection, prevention, and response in China and the Greater Mekong Subregion.

It was followed by another $2 million on 26 February to support response against the outbreak in all its developing members, and a CNY130 million ($18.6 million) private sector loan to Wuhan-based pharmaceutical distributor Jointown Pharmaceutical Group Co Ltd to support continuous supply of essential medicines and personal protective equipment.

Updated Date:

also read

India reports less than 30,000 new COVID-19 cases after over four months; total toll at 4.2 lakh
India

India reports less than 30,000 new COVID-19 cases after over four months; total toll at 4.2 lakh

As many as 29,689 new coronavirus infections took the country's tally of COVID-19 cases to 3,14,40,951. The national recovery rate improved to 97.39 percent

Over 3.09 crore unutilised vaccine doses available with states and private hospitals, says Centre
India

Over 3.09 crore unutilised vaccine doses available with states and private hospitals, says Centre

It said that more than 45.37 crore vaccine doses have been provided to states and UTs so far through all sources and a further 59,39,010 doses are in the pipeline

COVID-19 vaccine production increasing, India may be first country to have DNA-based jab, Mansukh Mandaviya tells RS
India

COVID-19 vaccine production increasing, India may be first country to have DNA-based jab, Mansukh Mandaviya tells RS

Replying to a short discussion on COVID-19 management in Rajya Sabha, the minister said technology transfer to several companies has started and they will begin production in the coming days